At the IGTP TODAY
The 3rd Innomed Awards brought together professionals from research, healthcare, entrepreneurship and investment, with the presentation of the 15 projects taking part in the new edition of GrowInn and recognition for the seven projects with the greatest potential.
The GCAT team at IGTP has developed PolyGenie, a new open tool that enables researchers to explore and reuse genomic data more easily. Designed to support large-scale genetic association studies, the platform advances GCAT's commitment to FAIR data and Open Science. Its development and application to the GCAT cohort are described in NAR Genomics and Bioinformatics.
IGTP will coordinate INTERACT-NF, a new European COST Action that will bring together 68 researchers from 13 countries to advance research on neurofibromatosis and schwannomatosis. The network will foster collaboration between researchers, clinicians and patient organisations to address the main challenges associated with these rare diseases.
A multicentre study led by professionals from the CEEISCAT and the Institut Català d'Oncologia (ICO-IDIBELL), published in the Journal of Medical Virology, concludes that anal self-sampling for the detection and genotyping of human papillomavirus (HPV) is an accurate, feasible and well-accepted strategy among gay, bisexual and other men who have sex with men (GBMSM) and trans people in the Barcelona metropolitan area.
Roger Paredes (Germans Trias Hospital, IrsiCaixa and the Fight Infections Foundation) coordinates the international NAVIS study, launched by the WHO to advance knowledge of Andes hantavirus. The initiative also includes an advanced virology and immunology study coordinated by IrsiCaixa and IGTP Principal Investigators Julià Blanco and Nuria Izquierdo-Useros.
IGTP has concluded a new cycle of visits to its laboratories as a part of La Marató "Visita la Recerca" program. More than fifty people had the opportunity to explore the biomedical research carried out at the institute through talks, workshops, and guided tours of the laboratories and facilities.
A study led by the IVECAT group at IGTP has identified a key mechanism regulating the anti-inflammatory function of extracellular vesicles derived from mesenchymal stromal cells. The findings, published in the Journal of Extracellular Vesicles, provide new insights into the therapeutic potential of these vesicles in inflammatory diseases and ischaemic processes.
The DIVINE cohort brings together clinical data from 5,813 patients hospitalised with COVID-19 during the first four waves of the pandemic and makes it available to the scientific community through an open, accessible and reusable resource. Published in Scientific Data, this multicentre database has already contributed to several studies and aims to support further research into the clinical progression of COVID-19, associated risk factors and the development of predictive models.
A team from the IGTP, in collaboration with the Home Hospitalisation Service (HAD) of the Germans Trias i Pujol University Hospital and the technology company Doole Health, has evaluated the usability of an artificial intelligence-based voice assistant for the remote clinical monitoring of patients. The results show good acceptance among both healthcare professionals and patients, including individuals with limited access to or use of digital technologies.
_1780404906.jpeg)
The European project BT4ChildLC, led by IGTP, has advanced precision medicine for childhood liver cancer by combining large-scale biological data with innovative preclinical models to identify new biomarkers and therapeutic strategies. The results provide a strong foundation for future international studies and highlight the importance of collaboration in advancing research into rare paediatric cancers.
